TechnipFMC PLC diskutieren
TechnipFMC PLC
WKN: A2DJQK / Symbol: FTI / Name: FMC Technologies / Aktie / Öl & Gas - Ausrüstung und Service / Large Cap /
39,47 €
-0,37 %
TechnipFMC plc (NYSE: FTI) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for FTI provided by MarketBeat
TechnipFMC plc (NYSE: FTI) had its price target raised by analysts at Susquehanna from $40.00 to $45.00. They now have a "positive" rating on the stock.
Ratings data for FTI provided by MarketBeat
TechnipFMC plc (NYSE: FTI) had its price target raised by analysts at Evercore ISI from $42.00 to $46.00. They now have an "outperform" rating on the stock.
Ratings data for FTI provided by MarketBeat
TechnipFMC plc (NYSE: FTI) had its price target raised by analysts at Royal Bank Of Canada from $37.00 to $40.00. They now have an "outperform" rating on the stock.
Ratings data for FTI provided by MarketBeat
TechnipFMC plc (NYSE: FTI) had its price target raised by analysts at Barclays PLC from $45.00 to $51.00. They now have an "overweight" rating on the stock.
Ratings data for FTI provided by MarketBeat
TechnipFMC (NYSE:FTI) had its price target raised by analysts at JPMorgan Chase & Co. from $41.00 to $43.00. They now have an "overweight" rating on the stock.
Ratings data for FTI provided by MarketBeat
TechnipFMC (NYSE:FTI) was upgraded by analysts at BNP Paribas Exane from a "neutral" rating to an "outperform" rating. They now have a $47.00 price target on the stock.
Ratings data for FTI provided by MarketBeat
TechnipFMC (NYSE:FTI) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for FTI provided by MarketBeat
TechnipFMC (NYSE:FTI) had its price target raised by analysts at Royal Bank Of Canada from $40.00 to $47.00. They now have an "outperform" rating on the stock.
Ratings data for FTI provided by MarketBeat
TechnipFMC (NYSE:FTI) had its "outperform" rating reaffirmed by analysts at UBS Group AG.
Ratings data for FTI provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Johnson & Johnson diskutieren